Next Article in Journal
Selection of Candidate Monoclonal Antibodies for Therapy of Botulinum Toxin Type A Intoxications
Next Article in Special Issue
Blood Lines: Intraspecific and Interspecific Variations in Anticoagulant Actions of Agkistrodon Viperid Venoms
Previous Article in Journal
Botulinum Toxin and Deep Brain Stimulation in Dystonia
Previous Article in Special Issue
Isolation and Functional Characterization of Erythrofibrase: An Alfa-Fibrinogenase Enzyme from Trimeresurus erythrurus Venom of North-East India
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

The Clot Thickens: Differential Coagulotoxic and Cardiotoxic Activities of Anguimorpha Lizard Venoms

1
Adaptive Biotoxicology Lab, School of the Environment, University of Queensland, St Lucia, QLD 4072, Australia
2
Venomenal Volunteers, The Netherlands
3
Working Group Adder Research Netherlands, RAVON, 6525 ED Nijmegen, The Netherlands
4
FaunaVet Wildlife Consultancy, Glass House Mountains, QLD 4518, Australia
*
Author to whom correspondence should be addressed.
Toxins 2024, 16(6), 283; https://doi.org/10.3390/toxins16060283
Submission received: 29 May 2024 / Revised: 11 June 2024 / Accepted: 17 June 2024 / Published: 20 June 2024

Abstract

Despite their evolutionary novelty, lizard venoms are much less studied in comparison to the intense research on snake venoms. While the venoms of helodermatid lizards have long been assumed to be for defensive purposes, there is increasing evidence of toxic activities more useful for predation than defence (such as paralytic neurotoxicity). This study aimed to ascertain the effects of Heloderma, Lanthanotus, and Varanus lizard venoms on the coagulation and cardiovascular systems. Anticoagulant toxicity was demonstrated for the Varanus species studied, with the venoms prolonging clotting times in human and bird plasma due to the destructive cleavage of fibrinogen. In contrast, thromboelastographic analyses on human and bird plasmas in this study demonstrated a procoagulant bioactivity for Heloderma venoms. A previous study on Heloderma venom using factor-depleted plasmas as a proxy model suggested a procoagulant factor was present that activated either Factor XI or Factor XII, but could not ascertain the precise target. Our activation studies using purified zymogens confirmed FXII activation. Comparisons of neonate and adult H. exasperatum, revealed the neonates to be more potent in the ability to activate FXII, being more similar to the venom of the smaller species H. suspectum than the adult H. exasperatum. This suggests potent FXII activation a basal trait in the genus, present in the small bodied last common ancestor. This also indicates an ontogenetic difference in prey preferences in the larger Heloderma species paralleing the change in venom biochemistry. In addition, as birds lack Factor XII, the ability to clot avian plasma suggested an additional procoagulant site of action, which was revealed to be the activation of Factor VII, with H. horridum being the most potent. This study also examined the effects upon the cardiovascular system, including the liberation of kinins from kininogen, which contributes to hypotension induction. This form of toxicity was previously described for Heloderma venoms, and was revealed in this study was to also be a pathophysiological effect of Lanthanotus and Varanus venoms. This suggests that this toxic activity was present in the venom of the last common ancestor of the anguimorph lizards, which is consistent with kallikrein enzymes being a shared toxin trait. This study therefore uncovered novel actions of anguimorph lizard venoms, not only contributing to the evolutionary biology body of knowledge but also revealing novel activities to mine for drug design lead compounds.
Keywords: lizard; venom; evolution; coagulation; Heloderma; Varanus lizard; venom; evolution; coagulation; Heloderma; Varanus

Share and Cite

MDPI and ACS Style

Dobson, J.; Chowdhury, A.; Tai-A-Pin, J.; van der Ploeg, H.; Gillett, A.; Fry, B.G. The Clot Thickens: Differential Coagulotoxic and Cardiotoxic Activities of Anguimorpha Lizard Venoms. Toxins 2024, 16, 283. https://doi.org/10.3390/toxins16060283

AMA Style

Dobson J, Chowdhury A, Tai-A-Pin J, van der Ploeg H, Gillett A, Fry BG. The Clot Thickens: Differential Coagulotoxic and Cardiotoxic Activities of Anguimorpha Lizard Venoms. Toxins. 2024; 16(6):283. https://doi.org/10.3390/toxins16060283

Chicago/Turabian Style

Dobson, James, Abhinandan Chowdhury, Jeremie Tai-A-Pin, Harold van der Ploeg, Amber Gillett, and Bryan G. Fry. 2024. "The Clot Thickens: Differential Coagulotoxic and Cardiotoxic Activities of Anguimorpha Lizard Venoms" Toxins 16, no. 6: 283. https://doi.org/10.3390/toxins16060283

APA Style

Dobson, J., Chowdhury, A., Tai-A-Pin, J., van der Ploeg, H., Gillett, A., & Fry, B. G. (2024). The Clot Thickens: Differential Coagulotoxic and Cardiotoxic Activities of Anguimorpha Lizard Venoms. Toxins, 16(6), 283. https://doi.org/10.3390/toxins16060283

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop